Multifunctional Nanopolymers for Blood–Brain Barrier Delivery and Inhibition of Glioblastoma Growth through EGFR/EGFRvIII, c-Myc, and PD-1
Glioblastoma (GBM) is the most prevalent primary brain cancer in the pediatric and adult population. It is known as an untreatable tumor in urgent need of new therapeutic approaches. The objective of this work was to develop multifunctional nanomedicines to treat GBM in clinical practice using combi...
Guardado en:
Autores principales: | Rameshwar Patil, Tao Sun, Mohammad Harun Rashid, Liron L. Israel, Arshia Ramesh, Saya Davani, Keith L. Black, Alexander V. Ljubimov, Eggehard Holler, Julia Y. Ljubimova |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91053559e30d44f3896a6b91476c46a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
por: Julia Y. Ljubimova, et al.
Publicado: (2021) -
Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier
por: Valérie Lorin, et al.
Publicado: (2020) -
Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry
por: Hamid Salimi, et al.
Publicado: (2020) -
Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
por: Jennifer P. Newman, et al.
Publicado: (2017) -
Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature
por: Alotaibi BS, et al.
Publicado: (2021)